3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid has been researched along with atropine in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 4 (80.00) | 29.6817 |
2010's | 1 (20.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fadda, F; Mameli, M; Mancinelli, R; Rossetti, ZL; Vargiu, R | 1 |
Blaszczak, P; Dekundy, A; Kaminski, R; Turski, WA | 1 |
Avoli, M; D'Antuono, M; Kawasaki, H; Palmieri, C | 1 |
Dekundy, A; Kaminski, RM; Turski, WA; Zielinska, E | 1 |
Ebisui, E; Hirase, H; Hisatsune, C; Mikoshiba, K; Mishima, T; Nagai, T; Takata, N | 1 |
5 other study(ies) available for 3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid and atropine
Article | Year |
---|---|
Biphasic effects of NMDA on the motility of the rat portal vein.
Topics: 2-Amino-5-phosphonovalerate; Animals; Atropine; Enzyme Inhibitors; Excitatory Amino Acid Agonists; Excitatory Amino Acid Antagonists; In Vitro Techniques; Male; Muscarinic Antagonists; Muscle Contraction; Muscle, Smooth, Vascular; N-Methylaspartate; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Nitroprusside; Piperazines; Portal Vein; Rats; Rats, Wistar; Receptors, N-Methyl-D-Aspartate; Tetrodotoxin; Vasodilator Agents | 2000 |
On the interactions between antimuscarinic atropine and NMDA receptor antagonists in anticholinesterase-treated mice.
Topics: Acetylcholinesterase; Animals; Atropine; Brain; Chlorfenvinphos; Cholinesterase Inhibitors; Dizocilpine Maleate; Dose-Response Relationship, Drug; Drug Antagonism; Excitatory Amino Acid Antagonists; Lethal Dose 50; Male; Methomyl; Mice; Muscarinic Antagonists; Piperazines; Seizures | 2001 |
Network and intrinsic contributions to carbachol-induced oscillations in the rat subiculum.
Topics: 6-Cyano-7-nitroquinoxaline-2,3-dione; Action Potentials; Animals; Atropine; Bicuculline; Carbachol; Chelating Agents; Cholinergic Agonists; Egtazic Acid; Excitatory Amino Acid Antagonists; GABA Antagonists; Hippocampus; Male; Muscarinic Antagonists; Neural Pathways; Organophosphorus Compounds; Periodicity; Picrotoxin; Piperazines; Rats; Rats, Sprague-Dawley; Receptors, Glutamate | 2001 |
NMDA antagonists exert distinct effects in experimental organophosphate or carbamate poisoning in mice.
Topics: Animals; Atropine; Carbamates; Cholinesterase Inhibitors; Dichlorvos; Dizocilpine Maleate; Dose-Response Relationship, Drug; Drug Therapy, Combination; Lethal Dose 50; Male; Mice; N-Methylaspartate; Piperazines; Seizures | 2007 |
Astrocyte calcium signaling transforms cholinergic modulation to cortical plasticity in vivo.
Topics: Acetylcholine; Action Potentials; Afferent Pathways; Aniline Compounds; Animals; Astrocytes; Atropine; Basal Nucleus of Meynert; Calcium Signaling; Cholinergic Agents; Chromatography, High Pressure Liquid; Evoked Potentials, Somatosensory; Excitatory Amino Acid Antagonists; Fluoresceins; Inositol 1,4,5-Trisphosphate Receptors; Male; Mice; Mice, Knockout; Microdialysis; Muscarinic Antagonists; Nerve Growth Factors; Neuronal Plasticity; Neurons; Physical Stimulation; Piperazines; S100 Calcium Binding Protein beta Subunit; S100 Proteins; Serine; Somatosensory Cortex; Sulfonamides; Thiazoles; Vibrissae | 2011 |